Investor Overview

Investor Presentation
Financial News
Aug 9, 2019

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, today reported financial results for the three months ended June...

Jul 31, 2019

MDNA19 demonstrates robust efficacy and safety with or without checkpoint inhibitors in preclinical models; Clinical studies expected to commence in 2020 TORONTO and HOUSTON, July 31, 2019 /CNW/ -...

Stock Quote
Stock Chart
Upcoming Events
No events to display
Investor Contact
For more investor information, Please contact:
Elizabeth Williams, Chief Financial Officer
Email Alerts
* Required Fields